Top

News & Events

Spotlight

Spotlight

How to get your story printed – we asked the journalists

Whatever kind of life sciences company you are, it’s important to get your message out there and communicate your work to the right people. Media coverage can be an excellent way to do that, but getting interest from the top publications can be harder than it looks.

In August, we hosted the One Nucleus ‘BioWednesday’ event, inviting four leading life sciences journalists to share their industry insights, hearing from Clive Cookson, Financial Times; Amber Tong, Endpoints; Lucie Ellis, In Vivo; and Sabah Meddings, Sunday Times. Here, we share their top tips on how to create great stories and secure coverage.

Read more »

Bumper biodollar deals for biotech clients

Congratulations to our clients Fstar, Hookipa and Microbiotica, each pioneering disruptive technologies for the development of tomorrow’s therapeutics. They have announced bio-dollar deals collectively worth up to ~$1.4 billion.

Read more »

Guide to Best Practice Communications for R&D Based Biotechs Webinar

Listen to managing partner Sue Charles chair the BIA webinar on the principles and application of the Guide to Best Practice Communications for R&D based biotechs.

Read more »

The Impact of MiFID II on the UK Biotech Industry

MiFID II. An acronym that instils a broad set of emotions across the City of London, ranging from blind panic in some quarters to mild indifference in others. This widely quoted but little understood abbreviation of the second Markets in Financial Instruments Directive is already having an effect across the industry. However, the fact that each financial institution is interpreting the regulations in different ways show the level of confusion, with some continuing as if nothing has changed, whilst others feel that sending a piece of research to a PR is an invitation to buy or sell shares.

Read more »

The UK BIA has launched a Best Practice Guide for Communicating R&D Progress to Investors and the Public

We welcome the launch of a new BioIndustry Association (BIA) guide to help bioscience companies communicate their R&D clearly and effectively to investors and the public.

Drawing on our decades or experience of advising public and private biotech companies in the UK and globally, Instinctif Partners supported the development of the guide, which can be downloaded HERE.

Read our INSIGHT on the importance of best practice communications in the biotech sector HERE.

Read more »